Kormos et al identified factors predictive of right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device (LVAD). A patient at risk may benefit from preoperative optimization of right heart failure and/or biventricular support. The authors are from multiple institutions in the United States.